Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial

M.M. Nijkamp; P.N. Span; C.H.J. Terhaard; P.A.H. Doornaert; J.A. Langendijk; P.L.A. van den Ende; M. de Jong; A.J. van der Kogel; J. Bussink; J.H.A.M. Kaanders

doi:10.1016/j.ejca.2013.06.024

Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial

M.M. Nijkamp, P.N. Span, C.H.J. Terhaard, P.A.H. Doornaert, J.A. Langendijk, P.L.A. van den Ende, M. de Jong, A.J. van der Kogel, J. Bussink, J.H.A.M. Kaanders

Radiation Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	3202-3209
Journal	European Journal of Cancer
Volume	49
Issue number	15
DOIs	https://doi.org/10.1016/j.ejca.2013.06.024
Publication status	Published - 2013

Access to Document

10.1016/j.ejca.2013.06.024

Cite this

Nijkamp, M. M., Span, P. N., Terhaard, C. H. J., Doornaert, P. A. H., Langendijk, J. A., van den Ende, P. L. A., de Jong, M., van der Kogel, A. J., Bussink, J., & Kaanders, J. H. A. M. (2013). Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial. European Journal of Cancer, 49(15), 3202-3209. https://doi.org/10.1016/j.ejca.2013.06.024

@article{7341d2144d50404ead13ce3a2b09ff31,

title = "Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial",

author = "M.M. Nijkamp and P.N. Span and C.H.J. Terhaard and P.A.H. Doornaert and J.A. Langendijk and {van den Ende}, P.L.A. and {de Jong}, M. and {van der Kogel}, A.J. and J. Bussink and J.H.A.M. Kaanders",

year = "2013",

doi = "10.1016/j.ejca.2013.06.024",

language = "Undefined/Unknown",

volume = "49",

pages = "3202--3209",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon",

number = "15",

}

Nijkamp, MM, Span, PN, Terhaard, CHJ, Doornaert, PAH, Langendijk, JA, van den Ende, PLA, de Jong, M, van der Kogel, AJ, Bussink, J & Kaanders, JHAM 2013, 'Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial', European Journal of Cancer, vol. 49, no. 15, pp. 3202-3209. https://doi.org/10.1016/j.ejca.2013.06.024

Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial. / Nijkamp, M.M.; Span, P.N.; Terhaard, C.H.J. et al.

In: European Journal of Cancer, Vol. 49, No. 15, 2013, p. 3202-3209.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial

AU - Nijkamp, M.M.

AU - Span, P.N.

AU - Terhaard, C.H.J.

AU - Doornaert, P.A.H.

AU - Langendijk, J.A.

AU - van den Ende, P.L.A.

AU - de Jong, M.

AU - van der Kogel, A.J.

AU - Bussink, J.

AU - Kaanders, J.H.A.M.

PY - 2013

Y1 - 2013

U2 - 10.1016/j.ejca.2013.06.024

DO - 10.1016/j.ejca.2013.06.024

M3 - Article

C2 - 23867129

SN - 0959-8049

VL - 49

SP - 3202

EP - 3209

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 15

ER -